(Q44513206)

English

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.

scientific article

Statements

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer. (English)
Altorki NK
Keresztes RS
Flieder DB
Ferrara CA
Yankelevitz DF
Subbaramaiah K
Pasmantier MW
Dannenberg AJ
2645-2650

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit